Welcome to LookChem.com Sign In|Join Free
  • or
1-[2-(4-phenylbutyryl)cyclopent-2-enecarbonyl]pyrrolidine-2(S)-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

725265-84-9

Post Buying Request

725265-84-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

725265-84-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 725265-84-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,5,2,6 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 725265-84:
(8*7)+(7*2)+(6*5)+(5*2)+(4*6)+(3*5)+(2*8)+(1*4)=169
169 % 10 = 9
So 725265-84-9 is a valid CAS Registry Number.

725265-84-9Relevant academic research and scientific papers

A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors

Jarho, Elina M.,Ven?l?inen, Jarkko I.,Huuskonen, Juhani,Christiaans, Johannes A. M.,Garcia-Horsman, J. Arturo,Forsberg, Markus M.,J?rvinen, Tomi,Gynther, Jukka,M?nnist?, Pekka T.,Wallén, Erik A. A.

, p. 5605 - 5607 (2007/10/03)

With the aim to replace the natural amino acid proline by a proline mimetic structure, a cyclopent-2-enecarbonyl moiety was studied at the P2 position of prolyl oligopeptidase (POP) inhibitors. The cyclopent-2-enecarbonyl moiety proved to be an excellent proline mimetic at the P2 position of POP inhibitors. The replacement is particularly useful when increased lipophilicity is needed.

COMPOUNDS HAVING PROLYL OLIGOPEPTIDASE INHIBITORY ACTIVITY

-

Page 22-23, (2010/02/07)

The invention provides a compound of formula (I), wherein in the formula X, R1, R2 and R3 are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as a prolyl oligopeptidase inhibitor. The compounds of formula (I) can be used for the treatment of diseases or conditions where prolyl oligopeptidase inhibitors are indicated to be effective, for example for the treatment of neurodegenerative diseases, such as Alzheimer's disease and senile dementia

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 725265-84-9